Acura Pharmaceuticals Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

Late quarterly filing notification for Q2 2026

Late quarterly filing notification for Q1 2026

Late annual filing notification for FY 2025

Late quarterly filing notification for Q3 2025

Late quarterly filing notification for Q2 2025

Prospectuses and Registrations Filter

Registration of securities for employees

Registration withdrawal request

Registration of securities for employees

Exempt offering of securities

Removal from listing

Ownership Filter

Thangaraj Immanuel

Skelly William G

Thangaraj Immanuel

Skelly William G

News Filter

Amended Loan Schedule to Secured Promissory Note Dated November 10, 2022 Between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC

Amended Loan Schedule to Secured Promissory Note Dated November 10, 2022 Between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC

Amended Loan Schedule to Secured Promissory Note Dated November 10, 2022 Between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC

Amended Loan Schedule to Secured Promissory Note Dated November 10, 2022 Between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC

Amended Loan Schedule to Secured Promissory Note Dated November 10, 2022 Between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Confidential treatment order

Confidential treatment order

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC